# Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants

> **NCT05134337** · PHASE1 · COMPLETED · sponsor: **Loxo Oncology, Inc.** · enrollment: 27 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LOXO-305
- **DRUG:** Itraconazole
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT05134337
- **Lead sponsor:** Loxo Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-12
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05134337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05134337, "Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05134337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*